T. Rowe Price Health Sciences Fund I Class (THISX)

Fund Assets	12.18B
Expense Ratio	0.67%
Min. Investment	$1,000,000
Turnover	n/a
Dividend (ttm)	10.40
Dividend Yield	13.72%
Dividend Growth	127.21%
Payout Frequency	Annual
Ex-Dividend Date	Dec 16, 2024

Previous Close	75.79
YTD Return	-4.50%
1-Year Return	2.19%
5-Year Return	39.61%
52-Week Low	72.14
52-Week High	102.82
Beta (5Y)	0.69
Holdings	236
Inception Date	Mar 24, 2016

About THISX

The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: THISX
• Share Class: T. Rowe Price Health Sciences Fund-i Class
• Index: S&P 500 TR

Performance

THISX had a total return of 2.19% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.80%.

Top 10 Holdings

46.67% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	7.11%
Intuitive Surgical, Inc.	ISRG	4.92%
Stryker Corporation	SYK	4.45%
Thermo Fisher Scientific Inc.	TMO	3.94%
ARGENX SE	n/a	3.54%
Vertex Pharmaceuticals Incorporated	VRTX	3.27%
Boston Scientific Corporation	BSX	3.14%
Danaher Corporation	DHR	3.07%
Alnylam Pharmaceuticals, Inc.	ALNY	2.51%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2024	$10.4019	Dec 17, 2024
Dec 15, 2023	$4.578	Dec 18, 2023
Dec 15, 2022	$1.5867	Dec 16, 2022
Dec 15, 2020	$1.020	Dec 16, 2020
Dec 16, 2019	$5.120	Dec 17, 2019
Dec 14, 2018	$4.490	Dec 17, 2018